We are live on
!
Find out more
PA
Probity Advisors Portfolio holdings
AUM
$631M
1-Year Est. Return
17.4%
This Fund
S&P 500
This Quarter
Est. Return
+2.11%
1 Year Est. Return
+17.4%
3 Year Est. Return
+41.22%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$301M
AUM Growth
+$10.4M
(+3.6%)
Cap. Flow
+$5.1M
Cap. Flow
% of AUM
1.69%
Top 10 Holdings %
Top 10 Hldgs %
41.47%
Holding
173
New
9
Increased
52
Reduced
101
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI International Developed Markets ETF
IDEV
|
+$1.44M |
| 2 |
iShares S&P 500 Value ETF
IVE
|
+$976K |
| 3 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$641K |
| 4 |
iShares S&P 500 Growth ETF
IVW
|
+$637K |
| 5 |
iShares S&P Small-Cap 600 Value ETF
IJS
|
+$595K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$534K |
| 2 |
AGN
Allergan plc
AGN
|
+$284K |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$277K |
| 4 |
Crown Castle
CCI
|
+$209K |
| 5 |
Broadcom
AVGO
|
+$202K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.01% |
| 2 | Industrials | 4.1% |
| 3 | Healthcare | 3.95% |
| 4 | Consumer Staples | 3.87% |
| 5 | Financials | 3.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Biogen
BIIB
$29.7B
| $291K | 0.1% |
1,245
+138
| +12% | +$31.9K |
|
152
Walmart Inc
WMT
$858B
| $288K | 0.1% |
7,827
-801
| -9% | -$27.6K |
|
153
Bank of America
BAC
$430B
| $282K | 0.09% |
9,736
+48
| +0.5% | +$1.38K |
|
154
Phillips 66
PSX
$83.8B
| $265K | 0.09% |
2,831
-41
| -1% | -$3.68K |
|
155
Amgen
AMGN
$199B
| $263K | 0.09% |
1,425
-62
| -4% | -$11.1K |
|
156
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
$6.06B
| $261K | 0.09% |
8,699
-177
| -2% | -$5.27K |
|
157
Accenture
ACN
$84.7B
| $250K | 0.08% |
1,352
+6
| +0.4% | +$1.08K |
|
158
eBay
EBAY
$48.6B
| $239K | 0.08% |
6,061
-281
| -4% | -$10.6K |
|
159
Waste Management
WM
$95.3B
| $230K | 0.08% |
1,996
-343
| -15% | -$37.2K |
|
160
Kimberly-Clark
KMB
$35.5B
| $229K | 0.08% |
1,717
-57
| -3% | -$7.35K |
|
161
Cognizant
CTSH
$20.2B
| $227K | 0.08% |
3,586
+711
| +25% | +$46.6K |
|
|
KSU
162
DELISTED
Kansas City Southern
KSU
| $227K | 0.08% |
+1,862
| New | +$223K |
|
163
Qualcomm
QCOM
$178B
| $226K | 0.08% |
+2,966
| New | +$217K |
|
164
Bristol-Myers Squibb
BMY
$126B
| $213K | 0.07% |
4,698
-796
| -14% | -$37.1K |
|
165
Toronto Dominion Bank
TD
$197B
| $213K | 0.07% |
+3,657
| New | +$206K |
|
166
Quest Diagnostics
DGX
$25.2B
| $206K | 0.07% |
+2,027
| New | +$195K |
|
167
Infosys
INFY
$43.3B
| $206K | 0.07% |
19,299
-984
| -5% | -$10.4K |
|
168
iShares MSCI Emerging Markets ETF
EEM
$28.6B
| $200K | 0.07% |
4,671
| – | – |
|
169
Energy Transfer Partners
ET
$70.4B
| $198K | 0.07% |
14,044
+443
| +3% | +$6.56K |
|
|
170
Broadcom
AVGO
$1.86T
| – | – |
-6,730
| Closed | -$202K |
|
|
171
Crown Castle
CCI
$32.4B
| – | – |
-1,629
| Closed | -$209K |
|
|
AGN
172
DELISTED
Allergan plc
AGN
| – | – |
-1,941
| Closed | -$284K |
|
|
CELG
173
DELISTED
Celgene Corp
CELG
| – | – |
-2,119
| Closed | -$200K |
|
Similar funds
BI
SWP
EIM
AMM
WA
RFA
SWM
KCMH
Probity Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, Probity Advisors held 173 positions worth $301M, up 3.6% from $291M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Probity Advisors's Q2 2019 filing shows 9 new, 52 increased, 101 reduced and 4 closed positions. Its largest new stake was iShares Core MSCI International Developed Markets ETF: 26,305 shares worth $1.44M. The largest sale was DuPont de Nemours, an estimated $534K.
By sector, the portfolio is most concentrated in Technology at 5% of assets, down from 5% a quarter earlier, followed by Industrials and Healthcare.
- Probity Advisors's largest Q2 2019 buy was iShares Core MSCI International Developed Markets ETF: 26,305 shares worth $1.44M.
- Probity Advisors added most to iShares S&P 500 Value ETF in Q2 2019, an estimated $976K increase.
- Probity Advisors's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $534K.
- Probity Advisors fully exited Allergan plc in Q2 2019, selling an estimated $284K.
- Probity Advisors's ten largest holdings make up 41% of its $301M portfolio in Q2 2019.
- Probity Advisors opened 9 new positions and closed 4 in Q2 2019.
- Probity Advisors's portfolio value rose 3.6% quarter-over-quarter to $301M.
Based on Probity Advisors's 13F filing for Q2 2019, filed 8 Aug 2019.